InvestorsHub Logo
Followers 26
Posts 4067
Boards Moderated 0
Alias Born 12/26/2018

Re: TheDane post# 387947

Tuesday, 02/08/2022 9:35:02 PM

Tuesday, February 08, 2022 9:35:02 PM

Post# of 403048
Leo is the man. He's a CPA making over $500K/year doing a little quarterly paperwork while failing to meaningfully advance a drug pipeline or bring shareholders anything resembling an ROI.

He just rode the COVID wave and locked in enough money to pay his salary for another 5-6 years plus the money owed to him by the company.

The existing name brands have been tapped so we're acquiring another some other new asset that's even better than Kevetrin and Brilacidin. One more good shot at catching lightning in the bottle in baby pharma land.

If nothing else it will be one last good pump until the IPIX name is irreparably trashed so he can finally sell some shares at a decent level. I'll be doing the same.

Leo's only doing a bad job if you thought he was on your team. Leo eats first in all things. If there are scraps left for shareholders, great. If not, just good. Shareholders are here to pay his salary first, and get a return on investment second.

Aside from that, I'm itching for another roll of the dice at the Ehrlich casino. This time is different...I can feel it. Might buy some more for the 2022 Roth contribution tomorrow.

What's $6000/$0.05? about 120,000 shares....nice. Sweet add if that $4.00/share buyout comes through.

President and Chairman of the IPIX Bagholder's Club.
Don't listen to me...I've been buying IPIX since 2015.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News